Wall Street Zen Upgrades Movano (NASDAQ:MOVE) to Hold

Movano (NASDAQ:MOVE) was upgraded by investment analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Movano Trading Up 11.0%

Shares of NASDAQ MOVE opened at $8.39 on Friday. The firm has a market cap of $6.96 million, a PE ratio of -0.77 and a beta of 0.77. Movano has a 1-year low of $4.67 and a 1-year high of $62.80. The company has a fifty day moving average price of $8.47 and a 200 day moving average price of $7.46.

Movano (NASDAQ:MOVE) last released its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, beating the consensus estimate of ($7.00) by $2.27. The firm had revenue of $0.08 million for the quarter, compared to the consensus estimate of $3.88 million. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of MOVE. Baird Financial Group Inc. raised its holdings in shares of Movano by 3.6% in the 1st quarter. Baird Financial Group Inc. now owns 323,943 shares of the technology company’s stock valued at $593,000 after purchasing an additional 11,366 shares during the period. Clayton Partners LLC increased its position in Movano by 27.2% during the first quarter. Clayton Partners LLC now owns 143,476 shares of the technology company’s stock worth $263,000 after buying an additional 30,708 shares during the last quarter. Finally, Citadel Advisors LLC bought a new stake in Movano in the third quarter valued at approximately $28,000. Institutional investors own 16.64% of the company’s stock.

Movano News Roundup

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Shareholders approved key amendments and initiatives at the recent meeting, removing a source of corporate uncertainty and enabling planned corporate actions (capital-structure or governance changes). Investors often view such approvals as clearing the way for financings or restructurings that can stabilize a micro-cap name. Movano stockholders approve key amendments and initiatives
• Neutral Sentiment: Recent analyst / media write-ups are re-examining Movano’s outlook vs. peers, highlighting valuation and business-model questions but not issuing widespread upgrades — coverage that can attract attention but is unlikely on its own to sustain a rally. Analyzing Movano (NASDAQ:MOVE) and Health Catalyst (NASDAQ:HCAT)
• Negative Sentiment: Fundamentals remain challenging: recent quarterly results showed a smaller-than-expected EPS loss relative to estimates but revenue was extremely low and the company continues to report large operating losses and negative margins — factors that keep upside speculative until revenue and cash-flow trajectories improve.
• Negative Sentiment: Market structure risk — Movano has a very small market capitalization, low average daily volume and a wide range between its 52-week low and high. That combination makes the stock prone to outsized moves on limited news or low-volume trades, increasing short-term volatility and execution risk for investors.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.